PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
172.07%
Net income growth similar to CRK's 188.55%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
31.52%
D&A growth well above CRK's 3.77%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
223.75%
Well above CRK's 193.40% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-19.28%
Both reduce yoy usage, with CRK at -103.55%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.28%
Negative yoy usage while CRK is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-233.29%
Negative yoy while CRK is 181.13%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
39.67%
Some CFO growth while CRK is negative at -5.52%. John Neff would note a short-term liquidity lead over the competitor.
-9.23%
Both yoy lines negative, with CRK at -26.62%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-98.68%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
130.15%
We have some outflow growth while CRK is negative at -100.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
37.35%
We have mild expansions while CRK is negative at -50.23%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
99.12%
Lower share issuance yoy vs. CRK's 781.82%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
No Data
No Data available this quarter, please select a different quarter.